Topical substance P and corneal epithelial wound closure in the rabbit

Investigative Ophthalmology and Visual Science

Volumn 38, Issue 2, 1997, Pages 388-395

  Kingsley, Robert E ^a,b   Marfurt, Carl F ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE NORTHWEST   (United States)

^b UNIVERSITY OF NOTRE DAME   (United States)

Author keywords

CP 100,263 01; CP 99,994 01; n heptanol; neurokinin 1 (NK1) receptor; substance P1 7 fragment

Indexed keywords

CP 10026301; CP 9999401; NEUROKININ 1 RECEPTOR; NEUROKININ 1 RECEPTOR ANTAGONIST; SUBSTANCE P; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOAVAILABILITY; CONTROLLED STUDY; CORNEA EPITHELIUM; CORNEA INJURY; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; TRIGEMINUS GANGLION; WOUND CLOSURE; WOUND HEALING;

ADMINISTRATION, TOPICAL; ANIMALS; CORNEA; EPITHELIUM; MALE; NEUROKININ A; OPHTHALMIC SOLUTIONS; PIPERIDINES; RABBITS; RECEPTORS, NEUROKININ-1; STEREOISOMERISM; SUBSTANCE P; WOUND HEALING;

EID: 0031045701     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Zieske JD, Gipson IK. Agents that affect corneal wound healing: Modulation of structure and function. In: Albert DM, Jakobiec FA, Robinson NL, eds. Principles and Practice of Ophthalmology. Philadelphia: W. B. Saunders; 1994:1093-1109.
2. Maurice DM. The Cornea and Sclera. In: Davson H, ed. The Eye. New York: Academic Press; 1984:1-158.
3. Klyce SD, Crosson CE. Transport processes across the rabbit corneal epithelium: A review. Curr Eye Res. 1985;4:323-331.
4. Paton L. The trigeminal and its ocular lesions. Br J Ophthalmol. 1926;10:300-342.
5. Beuerman RW, Schimmelpfennig B. Sensory denervation of the cornea affects epithelial properties. Exp Neurol. 1980;69:196-201.
6. Araki K, Ohashi Y, Kinoshita S, Hayashi K, Kuwayama Y, Tano Y. Epithelial wound healing in the denervated cornea. Curr Eye Res. 1994;13:203-211.
7. Gallar J, Pozo MA, Rebollo I, Belmonte C. Effects of capsaicin on corneal wound healing. Invest Ophthalmol Vis Sci. 1990;31:1968-1974.
8. Tervo K, Tervo T, Eranko L, Eranko O, Cuello AC. Immunoreactivity for substance P in the Gasserian ganglion, ophthalmic nerve and anterior segment of the rabbit eye. Histochem J. 1981;13:435-443.
9. Stone RA, Laties AM, Brecha NC. Substance P-like immunoreactive nerves in the anterior segment of the rabbit, cat and monkey eye. Neuroscience. 1982;7:2459-2468.
10. Sasaoka A, Ishimoto I, Kuwayama Y, et al. Overall distribution of substance P nerves in the rat cornea and their three-dimensional profiles. Invest Ophthalmol Vis Sci. 1984;25:351-356.
11. Nishida T, Nakamura M, Mishima H, et al. Synergistic effects of Substance P with epidermal growth factor and insulin-like growth factor on corneal epithelial migration in culture. ARVO Abstracts. Invest Ophthalmol Vis Sci. 1993;33:S1276.
12. Nakamura M, Nishida T, Reid TW, Murphy CJ. Substance P (SP) enhances EGF stimulated corneal epithelial cell migration, however, this action is not mediated by the NK-1 or NK-2 receptors. ARVO Abstracts. Invest Ophthalmol Vis Sci. 1994;35:51331.
13. Reid TW, Murphy CJ, Iwahashi CK, Foster BA, Mannis MJ. Stimulation of epithelial cell growth by the neuro-peptide substance P. J Cell Biochem. 1993;52:476-485.
14. Garcia-Hirschfeld J, Lopez-Briones LG, Belmonte C. Neurotrophic influences on corneal epithelial cells. Exp Eye Res. 1994;59:597-605.
15. Bury RW, Mashford ML. Biological activity of C-terminal partial sequences of substance P. J Med Chem. 1976;19:854-856.
16. Kahl BF, Reid TW. Substance P and the eye. Prog Ret Eye Res. 1995;14:473-504.
17. Yajima H, Kitagawa K, Segawa T. Structure-activity correlations in SP. Chem Pharm Bull (Tokyo). 1973;21:2500-2506.
18. Cintron C, Hassinger L, Kublin CL, Friend J. A simple method for the removal of rabbit corneal epithelium utilizing n-heptanol. Ophthalmic Res. 1979;11:90-96.
19. Ormerod LD, Garsd A, Reddy CV, Gomes SA, Abelson MB, Kenyon KR. Dynamics of corneal epithelial healing after an alkali burn. Invest Ophthalmol Vis Sci. 1989;30:1784-1793.
20. Kwok LS. Kinematics of epithelial wound closure in the rabbit cornea. Doc Ophthalmol. 1991;77:1-38.
21. Zar JH. Comparing simple linear regression equations. In: Zar JH, ed. Biostatistical Analysis. Upper Saddle River, NJ: Prentice Hall; 1996:353-370.
22. Crosson CE, Klyce SD, Beuerman RW. Epithelial wound closure in the rabbit cornea. Invest Ophthalmol Vis Sci. 1986;27:464-473.
23. Mertaniemi P, Ylatupa S, Partanen P, Tervo T. Increased release of immunoreactive calcitonin generelated peptide (CGRP) in tears after excimer laser keratectomy. Exp Eye Res. 1995;60:659-665.
24. Unger WG. Review: Mediation of the ocular response to injury. J Ocular Pharm. 1990;6:337-353.
25. McLean S, Ganong A, Seymour PA, et al. Pharmacology of CP-99,994; a nonpeptide antagonist of the tachykinin neurokinin-1 receptor. J Pharmacol Exp Ther. 1993;267:472-479.
26. Denis P, Vardin V, Nordmann J, et al. Localization and characterization of substance P binding sites in rat and rabbit eyes. Invest Ophthalmol Vis Sci. 1991;32:1894-1902.
27. Wang ZY, Hakanson R. The rabbit iris sphincter contains NK1 and NK3 but not NK2 receptors: A study with selective agonists and antagonists. Regul Pept. 1993;44:269-275.
28. Stratford RE, Lee VHL. Ocular animopeptidase activity and distribution in the albino rabbit. Curr Eye Res. 1985;4:995-999.
29. Kashi SD, Lee VH. Hydrolysis of enkephalins in homogenates of anterior segment tissues of the albino rabbit eye. Invest Ophthalmol Vis Sci. 1986;27:1300-1303.
30. Lee VH, Carson LW, Kashi SD, Stratford RE, Jr. Metabolic and permeation barriers to the ocular absorption of topically applied enkephalins in albino rabbits. J Ocul Pharmacol 1986;2:345-352.
31. Igic R. Substance P inactivation by aqueous humor. Exp Eye Res. 1993;57:415-417.
32. Sheardown H, Wedge C, Chou L, Apel R, Rootman DS, Cheng Y-L. Continuous epidermal growth factor delivery in corneal epithelial wound healing. Invest Ophthalmol Vis Sci. 1993;34:3593-3600.
33. Friedberg ML, Pleyer U, Mondino BJ. Device drug delivery to the eye. Collagen shields, iontophoresis, and pumps. Ophthalmology. 1991;98:725-732.
34. Lee VHL. New directions in the optimization of ocular drug delivery. J Ocul Pharmacol. 1986;2:345-352.
35. Sugiura S, Matsuda H. Electron microscopic observations on the corneal epithelium after sensory denervation. Jpn J Ophthalmol. 1967;11:207-212.
36. Beuerman RW, Schimmelpfennig B, Burstein N. Anatomy of the denervated corneal epithelium. ARVO Abstracts. Invest Ophthalmol Vis Sci 1979;18:5126.
37. Gipson IK, Anderson RA. Actin filaments in normal and migrating corneal epithelial cells. Invest Ophthalmol Vis Sci. 1977;16:161-166.
38. Buck RC. Cell migration in repair of mouse corneal epithelium. Invest Ophthalmol Vis Sci. 1979;18:767-784.
39. Gipson IK, Westcott MJ, Brooksby NG. Effects of cytochalasins B and D and colchicine on migration of the corneal epithelium. Invest Ophthalmol Vis Sci. 1982;22:633-642.
40. Kuwayama Y, Stone RA. Distinct substance P and calcitonin gene-related peptide immunoreactive nerves in the guinea pig eye. Invest Ophthalmol Vis Sci. 1987;28:1947-1954.
41. Mikulec A, Monroe FA, Tanelian DL. EGF and CGRP increase in vitro corneal epithelial wound healing. ARVO Abstracts. Invest Ophthalmol Vis Sci. 1993;34:S3323.